Efficacy of Liposomal Bupivacaine for Transversus Abdominis Plane Block
Recruiting
N/A
Interventional Study
Postoperative Pain
Liposomal Bupivacaine
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 86 (estimated)
- Sponsor
- Tianjin First Central Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a single-center, randomized, single-blind, parallel-group clinical trial. The study aims to compare the analgesic efficacy of liposomal bupivacaine versus ropivacaine for transversus abdominis plane (TAP) block in patients undergoing laparoscopic cholecystectomy. Eligible participants will be randomly assigned to receive either liposomal bupivacaine or ropivacaine for TAP block during surg…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18-65 years, either gender.
* Patients scheduled for elective laparoscopic cholecystectomy.
* ASA physical status I-III.
* Able to provide written informed consent and complete the 3-month follow-up.
Exclusion Criteria:
* History of allergy to local anesthetics.
* Histor…
Contacts